Protara Therapeutics, Inc.

DB:1KPA Stock Report

Market Cap: €46.8m

Protara Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:1KPA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Sep 24Sell€246,229Opaleye Management Inc.Company158,901€1.55
10 Sep 24Sell€103,637Opaleye Management Inc.Company61,992€1.72
16 Jul 24Sell€25,571Opaleye Management Inc.Company11,396€2.24
11 Jul 24Sell€161,757Opaleye Management Inc.Company74,551€2.21
01 Jul 24Sell€16,412Opaleye Management Inc.Company8,288€1.98
28 Jun 24Sell€132,998Opaleye Management Inc.Company64,568€2.11
25 Jun 24Sell€26,846Opaleye Management Inc.Company12,725€2.11
31 May 24Sell€40,580Opaleye Management Inc.Company15,054€2.71
22 May 24Sell€120,378Opaleye Management Inc.Company42,800€2.82
17 May 24Sell€211,854Opaleye Management Inc.Company70,885€3.06
10 May 24Sell€526,414Opaleye Management Inc.Company182,300€2.89

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1KPA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,570,1787.61%
VC/PE Firms1,900,0009.21%
Hedge Funds1,989,1349.64%
Institutions6,273,69530.4%
General Public8,896,76543.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 81.5%.


Top Shareholders

Top 25 shareholders own 55.35% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.64%
Opaleye Management Inc.
1,989,134€4.5m-13.7%0.75%
9.21%
RA Capital Management, L.P.
1,900,000€4.3m0%0.05%
4.77%
StemPoint Capital LP
984,113€2.2m484%0.66%
4.01%
Jesse Shefferman
828,201€1.9m-1.02%no data
3.93%
Tavistock Life Sciences
811,627€1.8m288%0.13%
3.23%
Citadel Advisors LLC
665,372€1.5m2,460%no data
2.84%
Randall Marshall
585,600€1.3m0%no data
2.6%
Baker Bros. Advisors LP
536,832€1.2m169%0.01%
2.52%
Armistice Capital LLC
520,000€1.2m0%0.03%
2.33%
Velan Capital Partners LP
480,000€1.1m0%1.24%
2.07%
The Vanguard Group, Inc.
427,612€971.1k0%no data
1.47%
Heights Capital Management, Inc.
302,746€687.5k0%0.31%
0.88%
Ikarian Capital, LLC
180,712€410.4k-10.9%0.11%
0.76%
Two Sigma Investments, LP
155,773€353.7k689%no data
0.73%
Renaissance Technologies LLC
150,400€341.5k77.8%no data
0.68%
Geode Capital Management, LLC
140,526€319.1k69.5%no data
0.62%
Oppenheimer Asset Management Inc.
127,181€288.8k1,170%no data
0.56%
BlackRock, Inc.
115,273€261.8k273%no data
0.56%
Privium Fund Management (UK) Limited
114,708€260.5k-4.19%0.11%
0.48%
Woodline Partners LP
100,001€227.1k0%no data
0.39%
Two Sigma Advisers, LP
80,518€182.8k198%no data
0.37%
Marshall Wace LLP
77,351€175.7k0%no data
0.31%
Jacqueline Zummo
63,331€143.8k0%no data
0.21%
LPL Financial Corporation, Asset Management Arm
44,000€99.9k57.1%no data
0.18%
Canadian Imperial Bank of Commerce, Asset Management Arm
37,000€84.0k0%no data